Drug recall · October 14, 2020
NYSTATIN ORAL SUSPENSION recall
Why: Failed Impurties/Degradation Specifications: out of specification results for an impurity for one lot
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
NYSTATIN ORAL SUSPENSION, USP 100,000 units per mL Contains: Alcohol 0.5% v/v (Bubblegum Flavored) 16 fl. oz. (480 mL) Manufactured by: VistaPharm, Inc. Largo FL 33771, USA NDC 66689-008-16 UPC 6668900816,
- Lots / codes
Lots: 638800 Exp 10/21
- Quantity
- 14,244 16 oz bottles
- Company
- VistaPharm, Inc., Largo, FL
- Distribution
- Distributed Nationwide in the USA including Puerto Rico
- Initiated
- September 25, 2020 · Voluntary: Firm initiated
- Classified
- October 5, 2020
- Reported
- October 14, 2020
- Ended
- September 28, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Nystatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.